Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation

Sebastian Jobjornsson, Martin Forster, Paolo Pertile, Carl-Fredrik Burman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)298-311
Number of pages14
JournalJournal of health economics
Early online date5 Oct 2016
Publication statusPublished - Dec 2016

Bibliographical note

© 2016 Elsevier B.V. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

Cite this